Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexmedetomidine Infusion Versus Oral Melatonin for Prevention of Intensive Care Unit (ICU) Delirium; A Prospective Randomized Controlled Study

NCT06076668 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT06076668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06076668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexmedetomidine Infusion Versus Oral Melatonin for Prevention of Intensive Care Unit (ICU) Delirium; A Prospective Randomized Controlled Study
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Unknown status
Start date
October 16, 2023
Completion date
October 20, 2024
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium, dexmedetomidine, melatonin